Correction: Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy
There was a mistake in the caption of figure 2 as published. The name of the cell line U343 MG was incorrectly spelled as "U434 MG and U34mg". The corrected caption of figure 2 appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original version of this article has been updated.for a reason not seen here, please contact the journal's editorial office.
Authors
- Diana Spiegelberg (ORCID: https://orcid.org/0000-0002-1509-2142)
- Eleftherios Papalanis
- Mehran Hariri (ORCID: https://orcid.org/0000-0001-9916-6673)
- Hanna Berglund (ORCID: https://orcid.org/0009-0007-1754-1822)
- Jörg Berg (ORCID: https://orcid.org/0000-0001-6046-522X)
- Anna Staffas (ORCID: https://orcid.org/0000-0001-8373-7312)
- Julia Uffenorde
- Bo Stenerlöw
- Christer Malmberg
Institutions
- Uppsala University (SE)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-03-26
- DOI
- https://doi.org/10.3389/fonc.2026.1823700
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00